Amgen, GSK To Team Up On Denosumab Commercialization in Europe

 
• By The Pink Sheet Daily

Amgen's big bet on denosumab gets a boost from a Big Pharma partner in Europe, with U.S. rights intact.

More from Europe

More from Geography